Walmart Settles DOJ Opioid Case for Less Than Half of One Percent of Six-Month Profit
Walmart (NASDAQ:WMT) has settled a civil lawsuit with the U.S. Department of Justice over its pharmacies' alleged unlawful filling of opioid prescriptions for $50 million, which amounts to just 0.43% of its six-month net income of $11.7 billion as of July 31, 2026. The company admitted no liability and described the settlement amount as financially immaterial. The case had initially been framed by prosecutors as potentially reaching billions in penalties but was significantly weakened after a federal judge narrowed it in early 2024, improving Walmart's negotiating position. While the monetary cost is minimal, the agreement includes non-monetary compliance obligations such as tighter pharmacy oversight and an employee hotline for reporting suspicious dispensing. Walmart’s recent financial performance remains strong with Q1 FY27 net income of $5.33 billion and Q2 at $6.366 billion. The company raised its full-year adjusted EPS guidance, reflecting continued operational strength despite the settlement.
Tickers: $WMT
Topics: DOJ settlement opioid lawsuit pharmacy compliance Walmart